Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Plane makes forced landing
Carlson: US govt. stopped me
Speaks about Willis' dementia
Vote to authorize strike
Criticizes film franchises
Get married in Hawaii
In concussion protocol
To keep kids in NY for now
Krayzie Bone hospitalized
Menendez refuses to resign
New voice actors revealed
AI to translate podcasts
Applauds Writers Guild deal
Lowest-ever Antarctic ice
Key ISIS official captured
Crashes into soccer field
US offers Poland $2B loan
US sanctions CN, RU firms
1st Black female surgeon
Colts release CB Lammons
17-yr-old allegedly kills 3
Hamilton calls for AI in F1
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
144,000 results
NowThis News
6h
Experimental Treatment Pushed by ALS Patients Gets Day Before FDA, but Agency Unconvinced It Works
WASHINGTON (AP) — The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou ...
朝日新聞社11d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 JST Share Tweet list Print This image provided by Eisai in January 2023 shows vials and packaging for ...
5don MSN
Medical Moment: FDA approves first-ever drug to slow Alzheimer’s
There is no cure yet, but now, a newly FDA-approved drug is helping to slow its progression before it’s too late.
朝日新聞社1mon
FDA approves much-debated Alzheimer’s drug panned by experts
WASHINGTON--Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated ...
WSB Radio
1h
After US approval, Japan OKs Leqembi, its first Alzheimer's drug, developed by Eisai and Biogen
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies ...
Seeking Alpha17d
Vigil Neuroscience study for Alzheimer's drug to proceed with FDA restrictions
Vigil Neuroscience (NASDAQ:VIGL) said the FDA is allowing a Phase 1 clinical trial for its Alzheimer’s drug candidate VG-3927 to proceed with a partial clinical hold related to the maximum drug ...
Forbes14d
What To Know About The Alzheimer’s Drug Leqembi
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.
Washington Examiner24d
FDA needs to let go of its risk-averse regulatory model
The FDA also gave full approval to a drug called Leqembi, which slowed Alzheimer’s patients’ functional and cognitive decline by 27% over 18 months, according to trial data.
Science Daily3d
Alzheimer's Research News
Sep. 18, 2023 — Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that's what a research group is discovering. 'We have ...
The Financial Times22d
Vivek Ramaswamy’s FDA ‘corruption’ claims disavowed by Roivant
We’ll send you a myFT Daily Digest email rounding up the latest Vivek Ramaswamy news every morning. US biotech company Roivant Sciences has moved to distance itself from its founder, Vivek ...
Prevention2d
Alzheimer’s Is a Terrible Disease—Especially If You’re Black
Valene Campbell started to have a sinking feeling as she was standing in the security line at the airport. It was fall 2016, and she was headed to London for a birthday celebration. But Campbell ...
Science Daily3d
Alzheimer's News
Sep. 18, 2023 — Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that's what a research group is discovering. 'We have ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices